ITI Pharma and Healthcare Fund Regular vs DSP Healthcare Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
DSP Healthcare Fund - Regular Plan - Growth
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹233 Cr | ₹3179 Cr |
| Min Investment | ₹5000 | ₹100 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹100 |
| Launch Date | 08 Nov 2021 | 30 Nov 2018 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 18% |
| Expense Ratio | 2.35 | 1.9 |
| Manager | Rohan Korde | Jay Kothari |
| ISIN Code | INF00XX01BL5 | INF740KA1LD8 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | DSP Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 1 Month | -2.6% | -1.37% |
| 6 Month | -2.51% | 2.16% |
| 1 Year | -7.03% | -4.79% |
| 3 Year | 18.82% | 20.9% |
| 5 Year | - | 16.1% |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 6 Month | -3.25% | -0.39% |
| 1 Year | -1.61% | 4.63% |
| 3 Year | 13.79% | 16.77% |
| 5 Year | - | 16.77% |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 1 Year | 18.94% | 24.28% |
| 3 Year | 20.21% | 21.38% |
| 5 Year | - | 25.75% |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Standard Deviation | 15.68% | 14.59% |
| Sharp | 0.75% | 0.94% |
| Beta | 0.95% | 0.84% |
| Alpha | -3.33% | 0.30% |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Name | Rohan Korde | Jay Kothari |
| Total AUM | ₹4626 Cr | ₹0 Cr |
| Funds Managed | 10 | 20 |
| ITI Pharma and Healthcare Fund Regular - Growth | DSP Healthcare Fund - Regular Plan - Growth |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Others | 3.94 | 16.7 |
| Large Cap | 32.04 | 16.81 |
| Mid Cap | 36.31 | 13.8 |
| Small Cap | 27.72 | 52.69 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Others | 1.7 | 2.09 |
| Healthcare | 93.14 | 96.38 |
| Basic Materials | 2.87 | - |
| Industrials | 1.05 | - |
| Financial Services | 1.25 | 1.53 |
Top Comparisons
WhiteOak Capital Special Opportunities Fund-Reg (G)
3Y Returns0%
AXIS Nifty Bank Index Fund - Regular (G)
3Y Returns0%
Kotak Consumption Fund - Regular (G)
3Y Returns0%
HSBC Consumption Fund - Regular (G)
3Y Returns0%
Motilal Oswal Nasdaq 100 Fund of Fund- Regular Plan Growth
3Y Returns34.27%
HSBC Asia Pacific (Ex Japan) Dividend Yield Fund - Growth
3Y Returns18.69%
SBI Equity Savings Fund - Regular Plan - Growth
3Y Returns11.06%
HSBC Equity Savings Fund - Regular Growth
3Y Returns13.44%